4//SEC Filing
Hall Ashley 4
Accession 0001209191-21-064587
CIK 0001637715other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:49 PM ET
Size
7.2 KB
Accession
0001209191-21-064587
Insider Transaction Report
Form 4
Hall Ashley
Chief Development Officer
Transactions
- Award
Common Stock
2021-11-12+30,000→ 30,000 total - Award
Stock Option (right to buy)
2021-11-12+180,000→ 180,000 totalExercise: $8.85Exp: 2031-11-11→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award.
- [F2]1/4 of the shares subject to the stock option vest and become exercisable on October 11, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001801842
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:49 PM ET
- Size
- 7.2 KB